COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Benjamin Ungar, Jacob W. Glickman, Alexandra Golant, Celina Dubin, Olga Marushchak, Alyssa Gontzes, Daniela Mikhaylov, Giselle Singer, Danielle Baum, Nancy Wei, Antonio Sanin, Diana Gruenstein, Mark Lebwohl, Ana B. Pavel, Emma Guttman‐Yassky
Topics & Concepts
DupilumabAtopic dermatitisMedicineAsymptomaticInternal medicineCohortSeverity of illnessCoronavirus disease 2019 (COVID-19)Incidence (geometry)Logistic regressionEczema Area and Severity IndexDermatologyDiseaseInfectious disease (medical specialty)PhysicsOpticsDermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisDermatological and COVID-19 studies